| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 667,7 k € | -1.2% | 675,5 k € | +26.6% | 533,6 k € | -5.1% | 562,2 k € | -1.5% | 571,1 k € | -20.6% | 719,1 k € | +2.3% | 703,2 k € | +21.7% | 577,7 k € | -11.6% | 653,6 k € | -8.0% | 710,4 k € | +25.3% | 567,0 k € | +2.3% | 554,5 k € | -11.7% | 628,2 k € | +21.0% | 519,1 k € | -21.2% | 658,5 k € | -1.0% | 665,2 k € | -30.9% | 963,0 k € | |
| EBITDA | 58,1 k € | -37.7% | 93,1 k € | +94.0% | 48,0 k € | -32.6% | 71,2 k € | +5.2% | 67,7 k € | -72.4% | 245,4 k € | -14.3% | 286,5 k € | +66.5% | 172,1 k € | +47.3% | 116,8 k € | -44.2% | 209,3 k € | +60.7% | 130,3 k € | -31.0% | 188,8 k € | -27.9% | 262,0 k € | +19.4% | 219,4 k € | -13.8% | 254,6 k € | +15.8% | 219,8 k € | +14.1% | 192,6 k € | |
| Operating profit | 60,9 k € | -21.8% | 77,9 k € | +237.7% | 23,1 k € | -32.3% | 34,0 k € | -44.7% | 61,5 k € | -69.3% | 200,1 k € | -17.1% | 241,3 k € | +98.1% | 121,8 k € | +104.1% | 59,7 k € | -59.4% | 147,0 k € | +152.0% | 58,3 k € | -51.1% | 119,2 k € | -49.7% | 237,1 k € | +23.0% | 192,7 k € | -15.5% | 228,1 k € | +36.4% | 167,2 k € | +17.3% | 142,6 k € | |
| Profit/loss | 37,7 k € | -28.4% | 52,6 k € | +323.5% | 12,4 k € | -43.3% | 21,9 k € | -42.2% | 37,9 k € | -66.3% | 112,7 k € | -18.3% | 137,9 k € | +100.3% | 68,9 k € | +154.8% | 27,0 k € | -69.1% | 87,6 k € | +170.6% | 32,4 k € | -53.5% | 69,6 k € | -55.6% | 156,9 k € | +23.2% | 127,3 k € | -24.1% | 167,7 k € | +55.8% | 107,6 k € | +27.2% | 84,6 k € | |
| Equity | 749,9 k € | +5.0% | 714,2 k € | -15.9% | 849,1 k € | -11.5% | 959,3 k € | -4.0% | 999,2 k € | +20.3% | 830,6 k € | +15.0% | 722,1 k € | +22.7% | 588,7 k € | +12.4% | 523,6 k € | +4.6% | 500,7 k € | +19.9% | 417,5 k € | +17.2% | 356,3 k € | +22.9% | 290,0 k € | -20.8% | 366,4 k € | +4.5% | 350,6 k € | +51.3% | 231,8 k € | +18.1% | 196,3 k € | |
| Total assets | 1,3 M € | -5.4% | 1,3 M € | -4.0% | 1,4 M € | -9.9% | 1,5 M € | -1.0% | 1,6 M € | +0.3% | 1,5 M € | -4.4% | 1,6 M € | +8.6% | 1,5 M € | -2.0% | 1,5 M € | +3.0% | 1,5 M € | -2.6% | 1,5 M € | +9.3% | 1,4 M € | -22.0% | 1,8 M € | +76.9% | 1,0 M € | +11.0% | 905,7 k € | -2.5% | 929,3 k € | -3.0% | 958,1 k € | |
| Cash | 67,9 k € | -64.7% | 192,4 k € | -32.9% | 286,6 k € | -16.8% | 344,5 k € | -14.4% | 402,4 k € | +26.9% | 317,1 k € | -15.9% | 377,0 k € | +110.0% | 179,5 k € | +51.1% | 118,8 k € | -30.8% | 171,8 k € | -11.1% | 193,3 k € | +33.9% | 144,4 k € | -29.2% | 204,1 k € | -31.6% | 298,5 k € | +82.0% | 164,0 k € | +338.0% | 37,4 k € | +183.7% | 13,2 k € | |
| Debts | 278,7 k € | -2.7% | 286,6 k € | +61.1% | 177,9 k € | +1.7% | 174,9 k € | +37.1% | 127,6 k € | -55.7% | 287,9 k € | -38.2% | 466,2 k € | -1.9% | 475,4 k € | -15.9% | 565,5 k € | +3.2% | 547,9 k € | -17.9% | 667,1 k € | +12.1% | 594,9 k € | -43.7% | 1,1 M € | +393.8% | 214,0 k € | +63.2% | 131,1 k € | -52.1% | 274,0 k € | -26.6% | 373,2 k € | |
| Staff | 12,7 | — | — | 10,1 | 12 | 9,8 | 10,4 | 11,9 | 12,3 | 12 | 9,3 | 8,5 | 9,1 | 9,7 | 9 | 9,1 | 9 | |||||||||||||||||
Public limited company · Gembloux · incorporated on 11/01/2002 · 12,7 ETP
Public limited company profitable and well capitalised. Cash position declining (-64.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SURGICAL INSTRUMENTS BELGIUM is a Public limited company incorporated in 2002. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Gembloux. It employs on average 12,7 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette